IRF4 and primary biliary cholangitis: Furthermore, our discovery of the effects of JAK inhibitor modulation of the STAT6-IRF4 pathway on macrophage polarization opens up a novel strategy for the clinical management of PBC and other immunological disorders in which macrophages exhibit a pathogenic role.